Quantitative Proteomic Profiling of Cerebrospinal Fluid to Identify Candidate Biomarkers for Alzheimer's Disease
PROTEOMICS - CLINICAL APPLICATIONS2018Vol. 13(4), pp. e1800105–e1800105
Citations Over TimeTop 10% of 2018 papers
Gajanan Sathe, Chan Hyun Na, Santosh Renuse, Anil K. Madugundu, Marilyn Albert, Abhay Moghekar, Akhilesh Pandey
Abstract
The proteins that are found to be altered in the CSF of patients with AD could be used for monitoring disease progression and therapeutic response and perhaps also for early detection once they are validated in larger studies.
Related Papers
- Susquehanna Chorale Spring Concert "Roots and Wings"(2017)
- → DETERMINING QUALITY REQUIREMENTS AT THE UNIVERSITIES TO IMPROVE THE QUALITY OF EDUCATION(2018)
- → Genentech taps Affimed’s antibodies(2018)
- Enxerto livre de arteria epigastrica inferior: avaliacao hemodinamica e angiografica pre e pos-operatoria(1988)
- → KOMPLIKASI REGIONAL ANESTESI PADA PEDIATRIK(2023)